Research programme: non-nucleoside reverse transcriptase inhibitors - GlaxoSmithKline

Drug Profile

Research programme: non-nucleoside reverse transcriptase inhibitors - GlaxoSmithKline

Alternative Names: 678248; GSK 3968A; GSK3986A; GW 3011; GW 4511; GW 4751; GW 8248; GW 8248X; GW 8635

Latest Information Update: 19 Apr 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator GlaxoSmithKline
  • Class Amides; Benzophenones
  • Mechanism of Action Non-nucleoside reverse transcriptase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported HIV infections

Most Recent Events

  • 21 Aug 2008 Pharmacodynamics and pharmacokinetics data from a preclinical trial in HIV infections presented at the 236th American Chemical Society National Meeting (236th-ACS-2008)
  • 28 Jul 2003 Data presented at the 2nd IAS Conference on HIV Pathogenesis and Treatment (IAS-2003) have been added to the Viral infections pharmacodynamics section ,
  • 06 May 2003 Data presented at the 16th International Conference on Antiviral Research (ICAR-2003) have been added to the Viral infections therapeutic trials section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top